ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 7, Pages 1563
Publisher
MDPI AG
Online
2021-03-30
DOI
10.3390/cancers13071563
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo
- (2020) Hong-Yuan Lu et al. LIFE SCIENCES
- Genome-wide CRISPR knockout screens identify ADAMTSL3 and PTEN genes as suppressors of HCC proliferation and metastasis, respectively
- (2020) Xiaoli Zhou et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index
- (2020) Kun‐Hao Bai et al. Cancer Medicine
- A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy
- (2020) Sooyeon Oh et al. Cancers
- Hepatitis C virus infection and tight junction proteins: The ties that bind
- (2020) Laurent Mailly et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review
- (2020) Xiao-yu Wei et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- MicroRNA‑574‑3p inhibits the malignant behavior of liver cancer cells by targeting ADAM28
- (2020) Zhongming Zha et al. Oncology Letters
- GPR50 Promotes Hepatocellular Carcinoma Progression via the Notch Signaling Pathway through Direct Interaction with ADAM17
- (2020) Subbroto Kumar Saha et al. Molecular Therapy-Oncolytics
- The quest for substrates and binding partners: A critical barrier for understanding the role of ADAMTS proteases in musculoskeletal development and disease
- (2020) Brandon Satz‐Jacobowitz et al. DEVELOPMENTAL DYNAMICS
- Stromal metalloproteinases: Crucial contributors to the tumor microenvironment
- (2020) Masayuki Shimoda et al. PATHOLOGY INTERNATIONAL
- ADAM28: Another ambivalent protease in cancer
- (2020) Céline Hubeau et al. CANCER LETTERS
- Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial–mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.
- (2020) Yunxiuxiu Xu et al. RNA Biology
- ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma
- (2020) Maria Arechederra et al. JOURNAL OF HEPATOLOGY
- Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
- (2019) Yoon Yang et al. SEMINARS IN LIVER DISEASE
- Proteomic discovery of substrates of the cardiovascular protease ADAMTS7
- (2019) Alain Colige et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A disintegrin-like and metalloproteinase domain with thrombospondin type 1 motif 9 (ADAMTS9) regulates fibronectin fibrillogenesis and turnover
- (2019) Lauren W. Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma
- (2019) Hiroaki Takaya et al. World Journal of Gastrointestinal Oncology
- Long noncoding LINC01551 promotes hepatocellular carcinoma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of microRNA‐122‐5p to regulate ADAM10 expression
- (2019) Jun Gao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers
- (2019) Fatemeh Moosavi et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma
- (2019) Hiroaki Takaya et al. BMC GASTROENTEROLOGY
- MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents
- (2019) Bin Yang et al. Cell Death & Disease
- ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells
- (2019) Jens Mattern et al. Scientific Reports
- Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma
- (2019) Lokau et al. Cancers
- Regulation of Fibrotic Processes in the Liver by ADAM Proteases
- (2019) Dirk Schmidt-Arras et al. Cells
- ADAM9 mediates the interleukin-6-induced Epithelial–Mesenchymal transition and metastasis through ROS production in hepatoma cells
- (2018) Yinying Dong et al. CANCER LETTERS
- ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma
- (2018) Yong Li et al. EXPERIMENTAL CELL RESEARCH
- Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells
- (2018) Jun Arai et al. INTERNATIONAL JOURNAL OF CANCER
- A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma
- (2018) Ruichao Chai et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Predominance of regorafenib over sorafenib: Restoration of membrane-bound MICA in hepatocellular carcinoma cells
- (2018) Jun Arai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- ADAMTS proteins in human disorders
- (2018) Timothy J. Mead et al. MATRIX BIOLOGY
- A Selective Extracellular Matrix Proteomics Approach Identifies Fibronectin Proteolysis by A Disintegrin-like and Metalloprotease Domain with Thrombospondin Type 1 Motifs (ADAMTS16) and Its Impact on Spheroid Morphogenesis
- (2018) Rahel Schnellmann et al. MOLECULAR & CELLULAR PROTEOMICS
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells
- (2018) Yingshi Zhang et al. Cell Death & Disease
- Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures
- (2018) Bassil Dekky et al. Oncotarget
- Iron-Overload triggers ADAM-17 mediated inflammation in Severe Alcoholic Hepatitis
- (2018) Jaswinder Singh Maras et al. Scientific Reports
- Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics
- (2018) Jr-Shiang Shiu et al. International Journal of Medical Sciences
- Adamts10 inactivation in mice leads to persistence of ocular microfibrils subsequent to reduced fibrillin-2 cleavage
- (2018) Lauren W. Wang et al. MATRIX BIOLOGY
- iNOS promotes CD24+CD133+ liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway
- (2018) Ronghua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma
- (2018) Xuetao Zhao et al. OncoTargets and Therapy
- Microenvironment-derived ADAM28 prevents cancer dissemination
- (2018) Catherine Gérard et al. Oncotarget
- A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma
- (2018) Baojia Zou et al. Cancer Management and Research
- ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia
- (2017) Maha Abdullah et al. Hematology
- ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions
- (2017) Mark A. Eckert et al. JOURNAL OF CELL SCIENCE
- miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma
- (2017) Yahui Liu et al. ONCOLOGY REPORTS
- Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma
- (2017) Ming-Jen Sheu et al. PLoS One
- Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus–related hepatocellular carcinoma metastasis through the upregulation of ADAM9
- (2017) Le-yang Xiang et al. TUMOR BIOLOGY
- Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy
- (2017) Bo Wu et al. Cell Death & Disease
- Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women
- (2017) Latha Kadalayil et al. Nature Communications
- Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma
- (2017) Hiroki Honda et al. Scientific Reports
- miR-203 Suppresses the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting Oncogene ADAM9 and Oncogenic Long Non-coding RNA HULC
- (2016) Daiwei Wan et al. Anti-Cancer Agents in Medicinal Chemistry
- The ADAMTS hyalectanase family: biological insights from diverse species
- (2016) C. M. Dancevic et al. BIOCHEMICAL JOURNAL
- The ADAMs family of proteases as targets for the treatment of cancer
- (2016) Maeve Mullooly et al. CANCER BIOLOGY & THERAPY
- In silico characterization of the interaction between LSKL peptide, a LAP-TGF-beta derived peptide, and ADAMTS1
- (2016) Marie-Amandine Laurent et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Determination of the substrate repertoire of ADAMTS2, 3, and 14 significantly broadens their functions and identifies extracellular matrix organization and TGF-β signaling as primary targets
- (2016) Mourad Bekhouche et al. FASEB JOURNAL
- TGF-β signalling and liver disease
- (2016) Isabel Fabregat et al. FEBS Journal
- SP1 and USF differentially regulate ADAMTS1 gene expression under normoxic and hypoxic conditions in hepatoma cells
- (2016) Sumeyye Aydogan Turkoglu et al. GENE
- IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice
- (2016) Juri Bergmann et al. HEPATOLOGY
- MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma
- (2016) Gang Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Role of epithelial to mesenchymal transition in hepatocellular carcinoma
- (2016) Gianluigi Giannelli et al. JOURNAL OF HEPATOLOGY
- ADAMTSL5 is upregulated in melanoma tissues in patients with idiopathic psoriasis vulgaris induced by nivolumab
- (2016) Y. Nonomura et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Oncogenic role of the Notch pathway in primary liver cancer
- (2016) JIE LU et al. Oncology Letters
- Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation
- (2016) SungWoo Hong et al. Oncotarget
- ADAMTS proteins as modulators of microfibril formation and function
- (2015) Dirk Hubmacher et al. MATRIX BIOLOGY
- ADAMTS proteases and cancer
- (2015) Santiago Cal et al. MATRIX BIOLOGY
- The roles of ADAMTS in angiogenesis and cancer
- (2015) Yi Sun et al. TUMOR BIOLOGY
- Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma
- (2015) Chongyi Li et al. Drug Design Development and Therapy
- The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family
- (2015) Richard Kelwick et al. GENOME BIOLOGY
- Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma
- (2015) Gaia Barisione et al. JAMA Ophthalmology
- The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition
- (2015) Michaël Ruff et al. PLoS One
- Association Between a Variant in ADAMTS5 and the Susceptibility to Hepatocellular Carcinoma in a Chinese Han Population
- (2014) Chongyi Li et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- TGF-β/Smad signaling during hepatic fibro-carcinogenesis (Review)
- (2014) KATSUNORI YOSHIDA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Antitumor function of microRNA-122 against hepatocellular carcinoma
- (2014) Kazuhiko Nakao et al. JOURNAL OF GASTROENTEROLOGY
- A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression
- (2014) Wei Zhang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Hedgehog Pathway Inhibition in Chondrosarcoma Using the Smoothened Inhibitor IPI-926 Directly Inhibits Sarcoma Cell Growth
- (2014) V. T. Campbell et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma
- (2014) YUWU LIU et al. ONCOLOGY REPORTS
- A disintegrin and metalloproteinase 17 regulates TNF and TNFR1 levels in inflammation and liver regeneration in mice
- (2013) Ryan S. McMahan et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17
- (2013) Xue-wei Yang et al. HEPATOLOGY RESEARCH
- TNF-α signalling and inflammation: interactions between old acquaintances
- (2013) Hana Zelová et al. INFLAMMATION RESEARCH
- The metalloproteinase ADAMTS1: A comprehensive review of its role in tumorigenic and metastatic pathways
- (2013) Izza de Arao Tan et al. INTERNATIONAL JOURNAL OF CANCER
- Hepatocytes Contribute to Immune Regulation in the Liver by Activation of the Notch Signaling Pathway in T Cells
- (2013) S. Burghardt et al. JOURNAL OF IMMUNOLOGY
- ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway
- (2013) Xiang-jun Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells
- (2013) SHAO YUAN et al. ONCOLOGY REPORTS
- Epidermal Growth Factor Receptor Signaling in Hepatocellular Carcinoma: Inflammatory Activation and a New Intracellular Regulatory Mechanism
- (2012) Carmen Berasain et al. DIGESTIVE DISEASES
- The ADAM family
- (2012) Laura Christian FLY
- Soluble c-Met protein as a susceptible biomarker for gastric cancer risk: A nested case-control study within the Korean Multicenter Cancer Cohort
- (2012) Jae Jeong Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of ADAMTS-1, ADAMTS-4, ADAMTS-5 and TIMP3 by hepatocellular carcinoma cell lines
- (2012) SHARON L. TURNER et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- High expression of ADAM8 correlates with poor prognosis in hepatocellular carcinoma
- (2012) Yun Zhang et al. SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND
- Expression of ADAM8 and its clinical values in diagnosis and prognosis of hepatocellular carcinoma
- (2012) Chao Jiang et al. TUMOR BIOLOGY
- Prediction of Hepatocellular Carcinoma Development by Plasma ADAMTS13 in Chronic Hepatitis B and C
- (2011) H. Ikeda et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma
- (2011) Changchun Zhou et al. FEBS LETTERS
- Protease profiling of liver fibrosis reveals the ADAM metallopeptidase with thrombospondin type 1 motif, 1 as a central activator of transforming growth factor beta
- (2011) Katia Bourd-Boittin et al. HEPATOLOGY
- The ADAMTS(L) family and human genetic disorders
- (2011) C. Le Goff et al. HUMAN MOLECULAR GENETICS
- Epithelial–mesenchymal transition in chronic liver disease: Fibrogenesis or escape from death?
- (2011) Massimo Pinzani JOURNAL OF HEPATOLOGY
- Involvement of ADAMs in tumorigenesis and progression of hepatocellular carcinoma: Is it merely fortuitous or a real pathogenic link?
- (2010) Antonio Mazzocca et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The roles of ADAMTS metalloproteinases in tumorigenesis and metastasis
- (2010) Laura Wagstaff Frontiers in Bioscience-Landmark
- Pivotal role of ADAMTS13 function in liver diseases
- (2010) Masahito Uemura et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Increased Expression of a Disintegrin and Metalloprotease-9 in Hepatocellular Carcinoma: Implications for Tumor Progression and Prognosis
- (2010) K. Tao et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- A splice variant of ADAMTS13 is expressed in human hepatic stellate cells and cancerous tissues
- (2010) Ryan Hunt et al. THROMBOSIS AND HAEMOSTASIS
- Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures
- (2009) Chiara Braconi et al. CANCER
- Anticancer Chemotherapy Inhibits MHC Class I-Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma
- (2009) K. Kohga et al. CANCER RESEARCH
- Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma
- (2009) Thomas Amann et al. CANCER SCIENCE
- Role of ADAMs in Cancer Formation and Progression
- (2009) M. J. Duffy et al. CLINICAL CANCER RESEARCH
- Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9
- (2009) Keisuke Kohga et al. HEPATOLOGY
- MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib
- (2009) Shoumei Bai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Disintegrin-like and Metalloprotease (Reprolysin-type) with Thrombospondin Type 1 Motif (ADAMTS) Superfamily: Functions and Mechanisms
- (2009) Suneel S. Apte JOURNAL OF BIOLOGICAL CHEMISTRY
- The Extracellular Matrix: Not Just Pretty Fibrils
- (2009) R. O. Hynes SCIENCE
- ADAM proteases: ligand processing and modulation of the Notch pathway
- (2008) A. Zolkiewska CELLULAR AND MOLECULAR LIFE SCIENCES
- MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma
- (2008) Wei-Chih Tsai et al. HEPATOLOGY
- Angiotensin II and epidermal growth factor receptor cross-talk mediated by a disintegrin and metalloprotease accelerates tumor cell proliferation of hepatocellular carcinoma cell lines
- (2008) Hidenori Itabashi et al. HEPATOLOGY RESEARCH
- Hepatic expression of A Disintegrin And Metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases
- (2008) Lutz Schwettmann et al. JOURNAL OF HEPATOLOGY
- Three-dimensional domain architecture of the ADAM family proteinases
- (2008) Soichi Takeda SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis
- (2008) Masanori Matsumoto et al. THROMBOSIS AND HAEMOSTASIS
- ADAM-15: a metalloprotease that mediates inflammation
- (2007) Laetitia Charrier-Hisamuddin et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation